Prolactin-secreting adenomas: pathogenesis, diagnosis, and management.
Fleseriu M, Varlamov EV, Akirov A, Langlois F, Petersenn S, Melmed S.
Lancet Diabetes Endocrinol. 2025 Oct;13(10):874-890. doi: 10.1016/S2213-8587(25)00227-X. Epub 2025 Aug 25.
Acromegaly: diagnostic challenges and individualized treatment.
Freda PU.
Expert Rev Endocrinol Metab. 2025 Jan;20(1):63-85. doi: 10.1080/17446651.2024.2448784. Epub 2025 Jan 5.
Consensus on acromegaly therapeutic outcomes: an update.
Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M, Salvatori R, Tsagarakis S, Losa M, Maffei P, Pereira AM, Geer EB, Katznelson L, van der Lely AJ, Bollerslev J, Esposito D, Webb SM, Zatelli MC, Valassi E, Neggers S, Chanson P, Ho KKY, Ioachimescu AG, Biller BMK, Samson SL, Kaiser UB, Schilbach K, Luque RM, Casanueva FF, Shimon I, Boguszewski CL, Biermasz N, Colao A, Pirchio R, Lamberts SWJ, Kadioglu P, Buchfelder M, Frara S, Chiloiro S, Petersenn S, Gadelha MR, Puig-Domingo M, Luger A, Brue T, Beckers A, Ferone D, Clemmons DR, Greenman Y, Marazuela M, Mortini P, Strasburger CJ, Giustina A.
Nat Rev Endocrinol. 2025 Nov;21(11):718-737. doi: 10.1038/s41574-025-01148-2. Epub 2025 Aug 13.
Paltusotine: First Approval.
Lee A.
Drugs. 2026 Feb;86(2):259-263. doi: 10.1007/s40265-025-02260-3. Epub 2025 Nov 26.
Diagnosis of Cushing's Disease.
Elenius H, Nieman LK.
Endocrinol Metab Clin North Am. 2025 Dec;54(4):537-548. doi: 10.1016/j.ecl.2025.06.001. Epub 2025 Jul 25.
GIGANTISM AND ACROMEGALY THROUGH HISTORY.
Malenica M, Trbojević T, Herceg S, Kukuruzović M, Šeparović I, Rotim N, Rotim K.
Acta Clin Croat. 2024 Oct;63(2):384-392. doi: 10.20471/acc.2024.63.02.15.
New treatments for acromegaly: Is a revolution underway?
Cristante J, Castinetti F.
Ann Endocrinol (Paris). 2025 Apr;86(2):101710. doi: 10.1016/j.ando.2025.101710. Epub 2025 Feb 15.
Medical Therapies of Cushing's Disease-Part 1.
Schwarz Y, Nowak E, Halperin R, Shah SN, Agrawal N, Feelders RA.
Endocrinol Metab Clin North Am. 2025 Dec;54(4):609-626. doi: 10.1016/j.ecl.2025.08.002.
Suppression of hypothalamic oestrogenic signal sustains hyperprolactinemia and metabolic adaptation in lactating mice.
Yu M, Feng B, Bean JC, Zhao Q, Yang Y, Liu H, Li Y, Eappen BP, Liu H, Tu L, Conde KM, Wang M, Chen X, Yin N, Threat DA, Xu N, Han J, Gao P, Zhu Y, Hadsell DL, He Y, Xu P, He Y, Wang C.
Nat Metab. 2025 Apr;7(4):759-777. doi: 10.1038/s42255-025-01268-z. Epub 2025 Apr 10.
Pituitary function.
Dingman JF.
N Engl J Med. 1971 Sep 9;285(11):617-9. doi: 10.1056/NEJM197109092851107.
